Neurofibromatosis, Investigator‐Initiated Research Award (DOD)

• DOI: http://doi.org/10.1002/fgc.31078
• Date: 21 May 2020
• Published date: 21 May 2020

Page 4 Federal Grants & Contracts ■ May 21, 2020

© 2020 Wiley Periodicals LLC, A Wiley Company All rights reserved • DOI: 10.1002/fgc

Grants alert (cont.)

EPSCoR Research Infrastructure Improvement

Program Track-1 (NSF)

Scope: The National Science Foundation seeks

applications for the Established Program to Stimulate

Competitive Research (EPSCoR) Research Infrastructure

Improvement (RII) Program Track-1 announcement.

Deadline: Aug. 3, 2020.

Funds: Up to $20 million total over ve years.

Eligibility: EPSCoR jurisdictions with current RII

Track-1 awards that expire before Oct. 1, 2021, and

those without current RII Track-1 awards.

Areas: NSF said funding supports research-driven

improvements to jurisdictions’ physical and cyber

infrastructure and human capital development in topical

areas selected by the jurisdiction’s EPSCoR steering

committee as having the best potential to improve future

R&D competitiveness.

➜ www.grants.gov; FON# 20-571

Neurobromatosis, Investigator-Initiated

Research Award (DOD)

Scope: The Defense Department’s U.S. Army Medical

Research Acquisition Activity seeks applications for the

Neurobromatosis (NF), Investigator-Initiated Research

Award announcement to support highly rigorous, high-

impact research projects that have the potential to make

an important contribution to NF research and/or patient

care.

Deadline: Pre-applications, June 25, 2020; applications,

July 9, 2020.

Funds: Approximately $4.6 million for ve Investigator-

Initiated Research Award applications.

Eligibility: Unrestricted.

Areas: DOD said areas of emphasis include biomarker

discovery, utility, development and validation; nontumor

manifestations, including but not limited to pain,

cognitive manifestations or sleep; and heterogeneity of

NF-related tumors; among others.

➜ www.grants.gov; FON# W81XWH-20-NFRP-IIRA

Neurobromatosis, Synergistic Idea Award

(DOD)

Scope: The Defense Department’s U.S. Army Medical

Research Acquisition Activity seeks applications for

the Neurobromatosis (NF), Synergistic Idea Award

announcement to support new ideas that represent

synergistic approaches to neurobromatosis research

involving two or three Principal Investigators.

Deadline: Pre-applications, June 25, 2020; applications,

July 9, 2020.

Funds: Approximately $3.2 million for approximately one

Synergistic Idea Award application.

Eligibility: Unrestricted.

Areas: DOD said areas of emphasis include:

heterogeneity of NF-related tumors, novel disease

and treatment response markers using genetics,

genomics, epigenetics, systems biology, metabolomics

or similar approaches; preclinical efficacy studies;

target identication and drug discovery; nutritional,

environmental and other modiers of NF; and health

services research.

➜ www.grants.gov; FON# W81XWH-20-NFRP-SIA

Breast Cancer Research Program Era of Hope

Scholar Award (DOD)

Scope: The Defense Department’s U.S. Army Medical

Research Acquisition Activity seeks applications for

the Breast Cancer Research Program Era of Hope

Scholar Award announcement to support individuals

early in their careers who have demonstrated signicant

potential to effect meaningful change in breast cancer.

Deadline: Pre-applications, Sept. 8, 2020; applications,

Sept. 22, 2020.

Funds: Approximately $4.8 million for one Era of Hope

Scholar Award application.

Eligibility: Unrestricted.

Areas: DOD said all Hope Scholar Award applications

must address at least one of the following over-

arching challenges: preventing breast cancer (primary

prevention); identifying determinants of breast cancer

initiation, risk or susceptibility; distinguishing deadly from

nondeadly breast cancers; or conquering the problems

of overdiagnosis and overtreatment; among others.

➜ www.grants.gov; FON# W81XWH-20-BCRP-

EOHS-2

Breast Cancer, Innovator Award (DOD)

Scope: The Defense Department’s U.S. Army Medical

Research Acquisition Activity seeks applications for

the Breast Cancer, Innovator Award announcement to

support visionary individuals who have demonstrated

exceptional creativity, innovative work and paradigm-

shifting leadership in any eld including, but not limited

to, breast cancer.

Deadline: Pre-applications, June 24, 2020; proposals,

Oct. 6, 2020.

Funds: Approximately $11.2 million for one Innovator

Award application.

Eligibility: Unrestricted.

Areas: DOD said all FY20 Breast Cancer Research

Program Innovator Award applications must address

(more)